Questcor Pharmaceuticals, Inc. (Headquarters) Says FDA Asks for More Data on Epilepsy Drug

Reuters -- Questcor Pharmaceuticals Inc said U.S. health regulators asked it to perform some additional analyses related to the marketing approval for its drug to treat infantile spasms, sending the company’s shares down about 32 percent.